2015
Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress
Koutsoulidou A, Kyriakides TC, Papadimas GK, Christou Y, Kararizou E, Papanicolaou EZ, Phylactou LA. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. PLOS ONE 2015, 10: e0125341. PMID: 25915631, PMCID: PMC4411125, DOI: 10.1371/journal.pone.0125341.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkersCase-Control StudiesDisease ProgressionFemaleHumansMaleMicroRNAsMiddle AgedMuscle WeaknessMyotonic DystrophyYoung AdultConceptsDM1 patientsMuscle-specific miRNAsMuscle wastingNatural historySensitive blood biomarkersPotential future therapiesDisease natural historyMyotonic dystrophy patientsAdult-onset muscular dystrophyMyotonic dystrophy type 1Useful molecular biomarkersParticipant seraSerum levelsMuscle weaknessBlood biomarkersClinical conditionsMuscle atrophyFuture therapiesPatientsPotential biomarkersDystrophy patientsMiR-133aType 1Progressive muscleMolecular biomarkers
2008
The effect of myotonic dystrophy transcript levels and location on muscle differentiation
Mastroyiannopoulos NP, Chrysanthou E, Kyriakides TC, Uney JB, Mahadevan MS, Phylactou LA. The effect of myotonic dystrophy transcript levels and location on muscle differentiation. Biochemical And Biophysical Research Communications 2008, 377: 526-531. PMID: 18930030, DOI: 10.1016/j.bbrc.2008.10.031.Peer-Reviewed Original Research